Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

BACKGROUND: To review our experience using methotrexate as a single long-term immunosuppressant (IS) therapy in neuromyelitis optica/neuromyelitis optica spectrum disorders (NMO/NMOSD). METHODS: We performed a retrospective chart review of all patients with a diagnosis of NMO/NMOSD, supported by a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanathan, Ramnath Santosh, Malhotra, Konark, Scott, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985587/
https://www.ncbi.nlm.nih.gov/pubmed/24628894
http://dx.doi.org/10.1186/1471-2377-14-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985587/
https://www.ncbi.nlm.nih.gov/pubmed/24628894
http://dx.doi.org/10.1186/1471-2377-14-51

Ejemplares similares